Fred Kielhorn is CEO of DeNovix Inc. in Wilmington Delaware.  DeNovix designs, manufactures and markets analytical instruments use in biotech research and development.  Instruments manufactured by DeNovix have received numerous Users Choice awards and are sold world-wide. 

Fred started his career in 1988 with DuPont and held positions in R&D, process development, logistics and market development over a 15-year period.  In 2000, he co-founded NanoDrop Technologies Inc. and held the position of Managing Director until 2007.  During this time the company developed and launched three successful products for biotech research and development.  In 2007, NanoDrop Technologies was acquired by Thermo Fisher Scientific.  After a brief transition period, he then formed the venture capital firm Kielvest LLC in 2008.  Over the next 3 years, Kielvest LLC made a number of investments into early-stage technology companies.  Through this experience Mr. Kielhorn realized that his passion was to be more directly involved in the operations of a company, which prompted the formation of DeNovix Inc. in January 2012.  Since inception, DeNovix has launched numerous analytical instruments for biotech research in the fields of spectrophotometry, fluorometry and imaging.

Fred and his wife, Lynne, reside in Wilmington DE and have 3 children (Ryan , Amanda and Jennifer).  Fred was inducted into the Academy in 2009.